Recently, a study reported that CD8+ CD19-CAR-T cells in ALL patients undergo exhaustion-related DNA methylation (125), thus demethylation therapy might provide means to ensure CAR-T cell fitness. This evidence concerns the gene CD19 and acute lymphoblastic leukemia.